Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
12/03/2009 | US20090298794 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
12/03/2009 | US20090298757 Oxyntomodulin analogues and their effects on feeding behaviour |
12/03/2009 | US20090298745 Treatment of Diabetes with Glycogen Phosphorylase Inhibitors |
12/03/2009 | US20090298744 Heterocyclic compounds as adenosine receptor antagonist |
12/03/2009 | US20090297598 Therapeutic combination |
12/03/2009 | US20090297592 Lipid Vesicle Composition |
12/03/2009 | DE202009012159U1 Salbe mit mehreren Schüssler-Salzen Ointment with several Schuessler salts |
12/03/2009 | CA2726262A1 Imidazopyridine and related analogs as sirtuin modulators |
12/03/2009 | CA2726231A1 Uses of conglutin-y |
12/03/2009 | CA2726148A1 Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
12/03/2009 | CA2725111A1 Substituted carbinol compound having a cyclic linker |
12/03/2009 | CA2724774A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
12/03/2009 | CA2724603A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
12/02/2009 | EP2128265A1 Method for glycosylation of flavonoid |
12/02/2009 | EP2128253A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same |
12/02/2009 | EP2128171A1 Agent for prevention or treatment of iron overload |
12/02/2009 | EP2128163A1 Spiro-ring compound |
12/02/2009 | EP2128158A1 Heterocyclic cyclopropyl-substituted FXR binding compounds |
12/02/2009 | EP2128138A1 Pyrazole compound |
12/02/2009 | EP2128136A1 2-phenylnicotinic acid derivative |
12/02/2009 | EP2127676A2 Treatment of obesity and related disorders |
12/02/2009 | EP2127663A1 Adiponectin production enhancer |
12/02/2009 | EP2127660A1 Agent for reducing visceral fat |
12/02/2009 | EP2127648A1 Pharmaceutical formulations of amyloid inhibiting compounds |
12/02/2009 | EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
12/02/2009 | EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
12/02/2009 | EP2125721A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
12/02/2009 | EP2125704A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
12/02/2009 | EP2125700A1 L-carnitine calcium fumarate, preparation method and application for the same |
12/02/2009 | EP2125023A2 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
12/02/2009 | EP2125003A2 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles |
12/02/2009 | EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
12/02/2009 | EP2124923A1 Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae. |
12/02/2009 | EP2124917A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
12/02/2009 | EP2124640A2 Agent for use in the case of fructose intolerance |
12/02/2009 | EP2124624A1 Cereal-based infant nutrition with fibre |
12/02/2009 | EP1902046B1 Piperidine derivatives useful as histamine h3 antagonists |
12/02/2009 | EP1896453B1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
12/02/2009 | EP1618086B1 Compounds for the treatment of metabolic disorders |
12/02/2009 | EP1606284B1 Compositions useful as protein kinase inhibitors |
12/02/2009 | EP1583742B1 Cb 1 receptour inverse agonists |
12/02/2009 | EP1523321B1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
12/02/2009 | EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor |
12/02/2009 | EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
12/02/2009 | EP1326500B1 Encased food product with contrasting components |
12/02/2009 | EP1248804B2 Recombinant antibodies to human interleukin-1 beta |
12/02/2009 | CN101595131A Methods of reducing phosphate absorption |
12/02/2009 | CN101595109A 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods |
12/02/2009 | CN101595104A Novel crystalline compound useful as GLK activator |
12/02/2009 | CN101595096A Substituted carbinol compound |
12/02/2009 | CN101595091A 1-naphthyl alkylpiperidine derivative |
12/02/2009 | CN101594909A IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
12/02/2009 | CN101594871A Pyrrolopyrimidine compounds and their uses |
12/02/2009 | CN101594861A Modulation of prostaglandin/cyclooxygenase metabolic pathways |
12/02/2009 | CN101594858A Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
12/02/2009 | CN101591374A Steroid compound, preparation method thereof, medicinal composition containing compound and application of compounds |
12/02/2009 | CN101591324A Three crystal forms of 5-methyl-7-methoxy-isoflavone, preparation method thereof, medicine composition thereof and application |
12/02/2009 | CN101591323A Five crystal forms of 7-hydroxy-isoflavone, preparation method thereof, medicine composition thereof and application |
12/02/2009 | CN101591321A Method for preparing 5,6,7,4'-tetrahydroxyflavone and application of 5,6,7,4'-tetrahydroxyflavone in medicaments |
12/02/2009 | CN101590240A Composition containing angiotensin II receptor antagonist, statin and folic acid as well as applications thereof |
12/02/2009 | CN101590239A Pharmaceutical composition containing uretic, statin and folic acid as well as applications thereof |
12/02/2009 | CN101590232A Pharmaceutical composition containing angiotensin converting enzyme inhibitors, lipid-lowering statins and nicotinic acid and application thereof |
12/02/2009 | CN101590221A Oral insulin medicament and preparation method thereof |
12/02/2009 | CN101590214A Ear patch for reducing weight |
12/02/2009 | CN101590175A Pharmaceutical preparation with function of regulating blood sugar level and production method thereof |
12/02/2009 | CN101590158A Method for extracting polyphenol from canna edulis ker waste residue |
12/02/2009 | CN101590150A Medicinal composition for reducing blood sugar and blood fat |
12/02/2009 | CN101590145A Medicinal composition for reducing blood sugar |
12/02/2009 | CN101590128A Lipid regulating and antioxidant effect-based method for evaluating quality of Jiangzhining |
12/02/2009 | CN101590123A Application of traditional Chinese medicine composition in preparing medicament for protecting damaged vascular endothelium |
12/02/2009 | CN101590116A Medicinal composition for reducing blood fat |
12/02/2009 | CN101590115A Medicinal composition for reducing blood fat |
12/02/2009 | CN101590111A Medicinal composition for preventing birth defect and improving memory |
12/02/2009 | CN101590106A Method for preparing antidiabetic preparation by taking cinnamon as raw material |
12/02/2009 | CN101590101A Prescription for curing type II diabetes and complications and preparation technology thereof |
12/02/2009 | CN101590097A Chinese herbal medicine prescription for reducing blood pressure and blood fat and improving sleep |
12/02/2009 | CN101590096A Medicinal composition for reducing blood fat |
12/02/2009 | CN101590094A Medicinal composition for preventing birth defects and improving memory |
12/02/2009 | CN101590093A Medicinal composition for preventing birth defect and improving memory |
12/02/2009 | CN101590090A Medicinal composition for preventing birth defect and improving memory |
12/02/2009 | CN101590089A Medicinal composition for preventing birth defect and improving memory |
12/02/2009 | CN101590082A Preparation for improving blood fat, blood pressure and blood sugar and protecting cardiovascular and cerebrovascular blood vessels and preparation method thereof |
12/02/2009 | CN101590079A Calcium supplement health care product and production method thereof |
12/02/2009 | CN101590063A Application of tanshinone IIA in preparing medicament for treating obesity and insulin resistance |
12/02/2009 | CN101590053A Drug combination containing nicotinic acid, statins compound and TZD compound |
12/02/2009 | CN101590037A Andrographolidume composition and application thereof |
12/02/2009 | CN101590033A Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method |
12/02/2009 | CN101590025A Simvastatin slow-release tablet and preparation method thereof |
12/02/2009 | CN101590007A Metformin hydrochloride/voglibose sugar-lowering oral preparation composition and preparation method thereof |
12/02/2009 | CN101589833A Preparation method of diabetes-alleviating beverage |
12/02/2009 | CN101589799A Multi-nutrient breakfast |
12/02/2009 | CN100564393C Separation of polypeptides comprising a racemized amino acid |
12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
12/02/2009 | CN100563717C Application of LYRM1 gene in preparing medicament for promoting fat cell proliferation |
12/02/2009 | CN100563697C Rhodiola rosea hippophae rhamnoides tablet and method of preparing the same |
12/02/2009 | CN100563682C Medicine compound made of haw leaf and rhodiola and its preparation method |
12/02/2009 | CN100563671C Fox immunity enhancer |
12/02/2009 | CN100563669C Process for preparing blumea balsamifera total flavone extract and blumea balsamifera flavone extract |
12/02/2009 | CN100563650C Indol-6 sulfonamide derivatives, their preparation and their use as 5-ht-6 modulators |
12/02/2009 | CN100563467C Face beautifying and body-building jelly, and its preparation method |